Zanidip

Zanidip

lercanidipine

Manufacturer:

Recordati

Distributor:

Zuellig Pharma

Marketer:

Abbott
Concise Prescribing Info
Contents
Lercanidipine HCl
Indications/Uses
Dosage/Direction for Use
10 mg/day. May be increased to 20 mg/day.
Administration
Should be taken on an empty stomach.
Contraindications
Left ventricular outflow tract obstruction, untreated CHF, unstable angina pectoris or recent (w/in 1 mth). Severe renal or hepatic impairment. Pregnancy & lactation.
Special Precautions
Sick sinus syndrome (w/o pacemaker). Moderate to severe left ventricular dysfunction.
Adverse Reactions
Peripheral edema, headache, flushing, tachycardia & palpitations.
Drug Interactions
Interact w/ metabolism & elimination w/ CYP3A4 inhibitors/inducers. Not to be taken w/ cyclosporin, grapefruit or grapefruit juice. Potentiated vasodilating effect w/ alcohol.
MIMS Class
ATC Classification
C08CA13 - lercanidipine ; Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
Presentation/Packing
Form
Zanidip FC tab 10 mg
Packing/Price
28's
Form
Zanidip FC tab 20 mg
Packing/Price
28's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in